On November 1st, we held the Cycle 6 IMPACT Pitch-Off, the final IMPACT pitch event of 2023. This event featured 10 digital health startups, leaders from Point32Health, Boston Scientific, UMass Chan Medical School and DeviceTalks, making for an inspirational and exciting evening.
For 12 weeks, the Cycle 6 cohort has been working with medical device leaders, industry experts and investors to prepare them for this competitive event. Each startup had 4 minutes to pitch their technology to a panel of judges and life sciences experts. For the Cycle 6 Pitch-Off, the startups were pitching for 11 different prizes from 7 different prize sponsors that could accelerate the commercialization of their medical device. (Each startup also received an IMPACT Program Award sponsored by Upteaming.)
Keynote by Kate Wallis, V.P. of Clinical Innovation with Point32Health
IMPACT Cycle 6 Pitch-Off started off with remarks from Kate Wallis, who discussed the “landscape of solutions in the healthcare space” that her and the Point32Health team see while working with startups and entrepreneurs. Kate accurately stated that “we are in the golden age of medicine” which was supported by the unique and impactful technologies pitched by startups throughout the event.
If you’ve been to any recent M2D2 events, you’ve encountered our favorite em-cee, Kyle Kruse (the Kruse Missile) V.P. of Marketing at Global Interconnect and Medtech Impact Podcast co-host alongside Richard Meiklejohn. Kyle kept the energy high as he introduced the Cycle 6 startup speakers and the judges on our IMPACT Expert Panel.
Announcing the IMPACT Accelerator Cycle 6 winners
After the judges and prize sponsor representatives deliberated, everyone was called together to hear the announcement of the winners.
Prize sponsor Upteaming kicked it off with a bang. Each startup in Cohort 6 received access to Upteaming’s peer-2-peer virtual networking platform.
Then, we dove into the prizes awarded to individual startups.
- The Best Showcase Presentation award from bene : studio was awarded to NucleusRx, Detact Diagnostics, and Embrace Prevention
- The Most Investable Startup award from Life Science Nation was presented to Cosmos Pharmaceuticals
- The Best Poster award from M2D2’s own marketing agency StitchDX was awarded myBiometry
- Most Innovative (sponsored by MPR): VenoVision
- The Biggest Potential Social Impact award, presented by Alira Health and selected by audience vote went to Rubitection
- The Pitch-Off Judges Award from Prime Path Medtech was awarded to myBiometry, JOGO Health, and Rubitection
- The Best Overall Startup award from Cycle 6 Sponsor Point32Health went to myBiometry
Looking ahead to our upcoming IMPACT cycles and events
Each IMPACT cycle highlights unique and innovative medical device startups developing novel solutions to improve diagnosis and treatment. During Cycle 6, we reconnected with some familiar startups, like myBiometry and Cosmos Pharmaceuticals, and met some new innovators, like Embrace Prevention Care and nucleusRx. Each startup did a fantastic job presenting their ideas to expert panelists and judges throughout the cycle.
Interested in applying to IMPACT Cycle 7? Applications are open NOW until November 30th. Learn more and start your application today!